SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.87-2.2%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who started this subject1/11/2002 11:35:22 AM
From: Ian@SI   of 52153
 
First time I've seen one of these. I won't post others to this thread or elsewhere again unless someone has some interest. Ian

+++++++

The following provides information on selected merger and acquisition deals.
All figures are updated by Dow Jones Corporate Filings Alert, with share prices
as of 10 a.m. EST Friday.

Annualized rate of return is based on Friday's date and the expected closing
date, and it isn't compounded. Expected closing dates are compiled from company
statements and reports, and when a time period is cited, that information is
provided along with that time period's midpoint date, which was used to make the
annualized return calculation.

Deals are listed alphabetically by acquirer, and premiums don't include
dividend or interest payments. Deal values don't include the assumption of debt.

-Amgen Inc. (AMGN), Immunex Corp. (IMNX)

Current discount: $1.45 or 4.92%
Acquirer: AMGN
Target: IMNX
Offer Per Share: 0.44 share and $4.50 cash
Value of offer per share: $29.47
Total deal value: $16.05 billion
Acquirer share price: $56.75
Target share price: $28.02
Expected closing: Second half of 2002 (10/2/02)
Annualized gain: 7.15%

-Chiron Corp. (CHIR), Matrix
Pharmaceuticals (MATX)

Current discount: 3 cents or 1.36%
Acquirer: CHIR
Target: MATX
Offer per share: $2.21 cash
Total deal value: $58.6 million
Target share price: $2.18
Expected closing: First quarter (2/14/02)
Annualized gain: 14.77%

-Hewlett-Packard Co. (HWP), Compaq Computer
Corp. (CPQ)

Current discount: $3.75 or 25.34%
Acquirer: HWP
Target: CPQ
Shares offered per share: 0.6325
Value of offer per share: $14.80
Acquisition value of target: $25.16 billion
Acquirer share price: $23.40
Target share price: $11.05
Expected closing: First half of 2002 (4/1/02)
Annualized gain: 154.86%

-MedImmune Inc. (MEDI), Aviron (AVIR)

Current discount: 4 cents or 0.07%
Acquirer: MEDI
Target: AVIR
Shares offered per share: 1.075
Value of offer per share: $51.84
Total deal value: $1.62 billion
Acquirer share price: $48.22
Target share price: $51.80
Expected closing: First quarter 2002 (2/14/02)
Annualized gain: 0.76%

-Medtronic Inc. (MDT), VidaMed Inc. (VIDA)

Current discount: 8 cents or 1.01%
Acquirer: MDT
Target: VIDA
Offer per share: $7.91 cash
Total deal value: $284.8 million
Target share price: $7.83
Expected closing: First quarter (2/14/02)
Annualized gain: 10.97%

-Millenium Pharmaceuticals Inc. (MLNM), Cor Therapeutics
Inc. (CORR)

Current discount: 11 cents or 0.49%
Acquirer: MLNM
Target: CORR
Shares offered per share: 0.9873
Value of offer per share: $23.15
Total deal value: $1.29 billion
Acquirer share price: $23.45
Target share price: $23.04
Expected closing: First quarter (2/13/02)
Annualized gain: 5.43%

-TLC Laser Eye Centers Inc. (TLCV), Laser Vision Centers
Inc. (LVCI)

Current discount: 5 cents or 1.78%
Acquirer: TLCV
Target: LVCI
Shares offered per share: 0.95
Value of offer per share: $2.70
Acquisition value of target: $69.8 million
Acquirer Share Price: $2.84
Target share price: $2.65
Expected closing: TLC's Fiscal 3Q (1/31/02)
Annualized gain: 33.06%
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext